AAPL314.37+1.71 (+0.55%) ▲|ABBV258.40+3.64 (+1.43%) ▲|ABT96.54+0.91 (+0.95%) ▲|ACN143.40+6.44 (+4.70%) ▲|ADBE230.12+12.05 (+5.52%) ▲|AMAT542.03-50.76 (-8.56%) ▼|AMD514.69-37.36 (-6.77%) ▼|AMGN369.85+3.41 (+0.93%) ▲|AMT165.29+3.18 (+1.96%) ▲|AMZN243.02-1.15 (-0.47%) ▼|AVGO367.72-6.18 (-1.65%) ▼|AXP350.63-5.40 (-1.52%) ▼|BA233.32-1.23 (-0.52%) ▼|BAC60.03+0.13 (+0.21%) ▲|BKNG181.93+0.90 (+0.50%) ▲|BLK1,006.34-4.87 (-0.48%) ▼|BMY58.46+1.76 (+3.10%) ▲|BNY152.00+2.04 (+1.36%) ▲|BRK-B506.60+0.02 (+0.00%) ▲|C141.79-2.07 (-1.44%) ▼|CAT914.32-55.60 (-5.73%) ▼|CL94.66+1.27 (+1.36%) ▲|CMCSA23.67+0.29 (+1.22%) ▲|COF202.80-3.70 (-1.79%) ▼|COP106.24+2.66 (+2.57%) ▲|COST948.98-1.27 (-0.13%) ▼|CRM171.50+5.85 (+3.53%) ▲|CSCO112.89-1.09 (-0.96%) ▼|CVS104.02+1.94 (+1.90%) ▲|CVX171.31+3.21 (+1.91%) ▲|DE598.40-36.85 (-5.80%) ▼|DHR193.78+0.16 (+0.08%) ▲|DIS97.82+0.41 (+0.42%) ▲|DUK128.98+3.01 (+2.39%) ▲|EMR137.78-3.78 (-2.67%) ▼|FDX313.25+3.32 (+1.07%) ▲|GD376.63-0.26 (-0.07%) ▼|GE366.92-11.76 (-3.11%) ▼|GEV1,038.56-113.48 (-9.85%) ▼|GILD134.36+4.75 (+3.66%) ▲|GM75.79-2.06 (-2.65%) ▼|GOOG365.50+0.60 (+0.16%) ▲|GOOGL368.52+2.06 (+0.56%) ▲|GS1,043.92-11.37 (-1.08%) ▼|HD346.12-4.53 (-1.29%) ▼|HON223.90-7.28 (-3.15%) ▼|IBM310.71+11.19 (+3.74%) ▲|INTC109.92-12.28 (-10.05%) ▼|INTU283.35+11.21 (+4.12%) ▲|ISRG426.55-6.28 (-1.45%) ▼|JNJ268.93+9.60 (+3.70%) ▲|JPM337.90+0.18 (+0.05%) ▲|KO84.24+1.28 (+1.54%) ▲|LIN536.26-4.27 (-0.79%) ▼|LLY1,229.10+29.04 (+2.42%) ▲|LMT537.36-0.65 (-0.12%) ▼|LOW221.98-1.81 (-0.81%) ▼|LRCX325.67-24.54 (-7.01%) ▼|MA532.77-0.33 (-0.06%) ▼|MCD282.47+2.97 (+1.06%) ▲|MDLZ60.27+1.10 (+1.86%) ▲|MDT84.49+1.43 (+1.72%) ▲|META604.81+4.52 (+0.75%) ▲|MMM157.00-2.15 (-1.35%) ▼|MO73.06+1.18 (+1.64%) ▲|MRK129.34+2.56 (+2.02%) ▲|MS220.97-1.13 (-0.51%) ▼|MSFT393.84+7.10 (+1.84%) ▲|MU922.13-62.63 (-6.36%) ▼|NEE88.25+0.81 (+0.93%) ▲|NFLX76.86+0.84 (+1.11%) ▲|NKE43.13-0.22 (-0.50%) ▼|NOW112.81+4.88 (+4.52%) ▲|NVDA195.21-0.34 (-0.17%) ▼|ORCL140.40-3.36 (-2.34%) ▼|PEP146.09+2.80 (+1.95%) ▲|PFE24.13+0.41 (+1.71%) ▲|PG151.56+2.25 (+1.51%) ▲|PLTR135.83+3.29 (+2.48%) ▲|PM186.98+2.22 (+1.20%) ▲|QCOM182.41-4.07 (-2.18%) ▼|RTX201.80+0.43 (+0.21%) ▲|SBUX103.24+1.13 (+1.11%) ▲|SCHW101.24+0.62 (+0.62%) ▲|SO98.06+2.07 (+2.16%) ▲|SPG229.23+4.23 (+1.88%) ▲|T20.98+0.40 (+1.92%) ▲|TMO516.78-0.82 (-0.16%) ▼|TMUS187.81+6.02 (+3.31%) ▲|TSLA407.68-12.09 (-2.88%) ▼|TXN292.00-11.50 (-3.79%) ▼|UBER73.41+0.99 (+1.36%) ▲|UNH426.99+9.00 (+2.15%) ▲|UNP283.00+0.41 (+0.14%) ▲|UPS112.12+2.10 (+1.91%) ▲|USB63.14+0.31 (+0.49%) ▲|V350.36-6.89 (-1.93%) ▼|VZ42.74+0.67 (+1.58%) ▲|WFC87.23-0.22 (-0.25%) ▼|WMT111.71+1.06 (+0.96%) ▲|XOM140.14+3.70 (+2.71%) ▲|AAPL314.37+1.71 (+0.55%) ▲|ABBV258.40+3.64 (+1.43%) ▲|ABT96.54+0.91 (+0.95%) ▲|ACN143.40+6.44 (+4.70%) ▲|ADBE230.12+12.05 (+5.52%) ▲|AMAT542.03-50.76 (-8.56%) ▼|AMD514.69-37.36 (-6.77%) ▼|AMGN369.85+3.41 (+0.93%) ▲|AMT165.29+3.18 (+1.96%) ▲|AMZN243.02-1.15 (-0.47%) ▼|AVGO367.72-6.18 (-1.65%) ▼|AXP350.63-5.40 (-1.52%) ▼|BA233.32-1.23 (-0.52%) ▼|BAC60.03+0.13 (+0.21%) ▲|BKNG181.93+0.90 (+0.50%) ▲|BLK1,006.34-4.87 (-0.48%) ▼|BMY58.46+1.76 (+3.10%) ▲|BNY152.00+2.04 (+1.36%) ▲|BRK-B506.60+0.02 (+0.00%) ▲|C141.79-2.07 (-1.44%) ▼|CAT914.32-55.60 (-5.73%) ▼|CL94.66+1.27 (+1.36%) ▲|CMCSA23.67+0.29 (+1.22%) ▲|COF202.80-3.70 (-1.79%) ▼|COP106.24+2.66 (+2.57%) ▲|COST948.98-1.27 (-0.13%) ▼|CRM171.50+5.85 (+3.53%) ▲|CSCO112.89-1.09 (-0.96%) ▼|CVS104.02+1.94 (+1.90%) ▲|CVX171.31+3.21 (+1.91%) ▲|DE598.40-36.85 (-5.80%) ▼|DHR193.78+0.16 (+0.08%) ▲|DIS97.82+0.41 (+0.42%) ▲|DUK128.98+3.01 (+2.39%) ▲|EMR137.78-3.78 (-2.67%) ▼|FDX313.25+3.32 (+1.07%) ▲|GD376.63-0.26 (-0.07%) ▼|GE366.92-11.76 (-3.11%) ▼|GEV1,038.56-113.48 (-9.85%) ▼|GILD134.36+4.75 (+3.66%) ▲|GM75.79-2.06 (-2.65%) ▼|GOOG365.50+0.60 (+0.16%) ▲|GOOGL368.52+2.06 (+0.56%) ▲|GS1,043.92-11.37 (-1.08%) ▼|HD346.12-4.53 (-1.29%) ▼|HON223.90-7.28 (-3.15%) ▼|IBM310.71+11.19 (+3.74%) ▲|INTC109.92-12.28 (-10.05%) ▼|INTU283.35+11.21 (+4.12%) ▲|ISRG426.55-6.28 (-1.45%) ▼|JNJ268.93+9.60 (+3.70%) ▲|JPM337.90+0.18 (+0.05%) ▲|KO84.24+1.28 (+1.54%) ▲|LIN536.26-4.27 (-0.79%) ▼|LLY1,229.10+29.04 (+2.42%) ▲|LMT537.36-0.65 (-0.12%) ▼|LOW221.98-1.81 (-0.81%) ▼|LRCX325.67-24.54 (-7.01%) ▼|MA532.77-0.33 (-0.06%) ▼|MCD282.47+2.97 (+1.06%) ▲|MDLZ60.27+1.10 (+1.86%) ▲|MDT84.49+1.43 (+1.72%) ▲|META604.81+4.52 (+0.75%) ▲|MMM157.00-2.15 (-1.35%) ▼|MO73.06+1.18 (+1.64%) ▲|MRK129.34+2.56 (+2.02%) ▲|MS220.97-1.13 (-0.51%) ▼|MSFT393.84+7.10 (+1.84%) ▲|MU922.13-62.63 (-6.36%) ▼|NEE88.25+0.81 (+0.93%) ▲|NFLX76.86+0.84 (+1.11%) ▲|NKE43.13-0.22 (-0.50%) ▼|NOW112.81+4.88 (+4.52%) ▲|NVDA195.21-0.34 (-0.17%) ▼|ORCL140.40-3.36 (-2.34%) ▼|PEP146.09+2.80 (+1.95%) ▲|PFE24.13+0.41 (+1.71%) ▲|PG151.56+2.25 (+1.51%) ▲|PLTR135.83+3.29 (+2.48%) ▲|PM186.98+2.22 (+1.20%) ▲|QCOM182.41-4.07 (-2.18%) ▼|RTX201.80+0.43 (+0.21%) ▲|SBUX103.24+1.13 (+1.11%) ▲|SCHW101.24+0.62 (+0.62%) ▲|SO98.06+2.07 (+2.16%) ▲|SPG229.23+4.23 (+1.88%) ▲|T20.98+0.40 (+1.92%) ▲|TMO516.78-0.82 (-0.16%) ▼|TMUS187.81+6.02 (+3.31%) ▲|TSLA407.68-12.09 (-2.88%) ▼|TXN292.00-11.50 (-3.79%) ▼|UBER73.41+0.99 (+1.36%) ▲|UNH426.99+9.00 (+2.15%) ▲|UNP283.00+0.41 (+0.14%) ▲|UPS112.12+2.10 (+1.91%) ▲|USB63.14+0.31 (+0.49%) ▲|V350.36-6.89 (-1.93%) ▼|VZ42.74+0.67 (+1.58%) ▲|WFC87.23-0.22 (-0.25%) ▼|WMT111.71+1.06 (+0.96%) ▲|XOM140.14+3.70 (+2.71%) ▲|
18.4 C
New York
Tuesday, July 7, 2026

Tag: research

Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26

Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.
Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.

New Index Ranks Vulnerabilities of 188 Nations to Climate Shocks

Columbia Climate School identifies 65 'Red Zone' nations across four separate climate scenarios. 43 nations in Sub-Saharan Africa, eight in Latin America and the Caribbean,...

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased to announce the results of voting at its 2025 annual general meeting of shareholders held on June 25, 2025, in Vancouver, British Columbia (the “Meeting”).

New Index Ranks Vulnerabilities of 188 Nations to Climate Shocks

Columbia Climate School identifies 65 'Red Zone' nations across four separate climate scenarios. 43 nations in Sub-Saharan Africa, eight in Latin America and the Caribbean,...

Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing  

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with increasing interest in...

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with increasing interest in...

ATRI UPDATES TWO KEY ENVIRONMENTAL RESEARCH RESOURCES

WASHINGTON, June 25, 2025 /PRNewswire/ -- The American Transportation Research Institute (ATRI) today released updated versions of its Sustainability and Idling Regulations Compendiums. The...

Organic Spirulina Market to Reach $515 Million by 2035, Growing at a CAGR of 13.5% from 2025, Says Meticulous Research®

Market Growth Driven by Rising Consumer Preference for Clean-Label Products, Premium Health Benefits, Expanding Organic Nutraceuticals Industry, and Growing Demand for Natural Food Colorants REDDING,...

Organic Spirulina Market to Reach $515 Million by 2035, Growing at a CAGR of 13.5% from 2025, Says Meticulous Research®

Market Growth Driven by Rising Consumer Preference for Clean-Label Products, Premium Health Benefits, Expanding Organic Nutraceuticals Industry, and Growing Demand for Natural Food Colorants REDDING,...

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its previously announced non-brokered private placement (the “Offering”) of common shares in the capital of the Company (the “Common Shares”).

Hyundai Hope on Wheels donates $250,000 to BC Children’s Hospital Foundation to support children facing cancer

Every year in B.C., approximately 130 children are diagnosed with cancer. As the province's only full-service acute-care hospital dedicated to children, BC Children's Hospital...

Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society

PALO ALTO, Calif., June 25, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics...

First CenterPoint Energy Resiliency Technology Summit showcases innovative new tools to help improve hurricane preparedness and response

Global technology leaders share best practices and demonstrate advanced technologies and AI tools being used to enhance storm preparedness and emergency response HOUSTON, June 25,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsResearch